Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 189 of 1,261
  1. US 11672775

    Treprostinil prodrugs

    United Therapeutics Corporation · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  2. US 11672776

    Multi-arm polymeric alkanoate conjugates

    Nektar Therapeutics · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  3. US 11672762

    Onapristone extended-release compositions and methods

    CONTEXT BIOPHARMA, INC. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  4. US 11672774

    Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  5. US 11672749

    Peptide exhibiting wrinkle-improving activity and uses thereof

    CAREGEN CO., LTD. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  6. US 11672801

    Compositions and methods for treating cancer

    United States Government as represented by the Department of Veterans Affairs · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  7. US 11674139

    Oligonucleotides for treating expanded repeat diseases

    Sarepta Therapeutics, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  8. US 11674121

    Platform for generating safe cell therapeutics

    The Regents of the University of California · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  9. US 11673853

    Small molecule AMPK activators

    THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  10. US 11672868

    Bicyclic peptide ligands specific for MT1-MMP

    BicycleRD Limited · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  11. US 11673893

    CDK inhibitors and their use as pharmaceuticals

    Prelude Therapeutics, Incorporated · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  12. US 11672876

    Imageable embolic microsphere

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  13. US 11672789

    Radiation mitigator and method of use thereof

    The Board of Regents of the University of Oklahoma · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  14. US 11672871

    Peptide oligonucleotide conjugates

    Sarepta Therapeutics, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  15. US 11673873

    Apelin receptor agonists and methods of use thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  16. US 11673867

    Sulfonamide derivative or pharmaceutically acceptable acid-addition salt

    The Board of Regents of the University of Texas System · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  17. US 11673864

    Pyridone amides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  18. US 11673860

    Crystalline siponimod fumaric acid and polymorphs thereof

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  19. US 11673866

    Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases

    The Regents of the University of California · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  20. US 11673896

    Pyridine compounds as allosteric SHP2 inhibitors

    Revolution Medicines, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  21. US 11673898

    Substituted inhibitors of menin-MLL and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  22. US 11673899

    Crystal form of thieno[2,3-c]pyridazine-4(1H)-one compound, preparation method therefor and use thereof

    Medshine Discovery Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  23. US 11673887

    N-acyl amino acid compounds and methods of use

    Pliant Therapeutics, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  24. US 11673902

    Isoindolinone and indazole compounds for the degradation of EGFR

    C4 THERAPEUTICS, INC. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.